Compare Nano Dimension Ltd - ADR (NNDM) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nano Dimension Ltd - ADR vs Nuwellis Inc — how do they compare? Nano Dimension Ltd - ADR trades at $1.56 (market cap $328.52M), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Nano Dimension Ltd - ADR is far larger — about 149.3× Nuwellis Inc's market cap, and Nano Dimension Ltd - ADR is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nano Dimension Ltd - ADR for 43 Days and Nuwellis Inc for 26 Days on average.
| NNDM | NUWE | |
|---|---|---|
Market Cap | $328.52M | $2.20M |
Volume | 1,160,945 | 121,544 |
Sector | Technology | Health |
52-Week High | $2.14 | $146.65 |
52-Week Low | $1.21 | $0.68 |
Typical Hold Time | 43 Days | 26 Days |
Enterprise Value | -$76.33M | -$1.52M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NNDM trades at $1.55, down 1.27% with bearish technical signals. The company shows revenue growth from $102M in 2025 to $121M in 2026 but continues to post significant losses with a -135.18% net income margin. Recent strategic moves include cost-cutting initiatives and leadership changes aimed at reducing cash burn. The stock faces headwinds from negative cash flow trends and persistent unprofitability despite improving sales.
Outlook remains challenging with substantial execution risks. The company's cash position of $758M provides runway, but continued losses and negative operating cash flow pose sustainability concerns. Investment opportunity exists if cost reductions translate to profitability, but high risk profile requires careful monitoring of quarterly execution against guidance.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
